A Nanaimo-based medical cannabis company has announced approval on its exports to Chile.
This will be its Tilray’s first venture into the South American market.
The company announced that they have received the necessary regulatory approvals making it possible to export and distribute Tilray medical cannabis in Chile.
Their products are now available on four continents around the world.
Tilray is partnering with Alef Biotechnology to import and distribute the goods in Chile.
Chilean law permits patients to access medical cannabis products under the supervision of a recommending physician. Right now, there are about 88,000 Chilean patients suffering from a diverse range of conditions who may be candidates for medical cannabis, according to TIlray.
The first shipment of Tilray products is expected to arrive in Chile by the end of February and will initially be available at select hospitals and pharmacies in Santiago.
Tilray currently supplies pharmaceutical-grade medical cannabis products like whole flower and oils, to thousands of patients, physicians, pharmacies, hospitals, governments and researchers around the world.
Tilray became the first medical cannabis producer in North America to be GMP certified in December 2016, meaning they met the most rigorous standard that manufacturers of medical products.
In 2016, Tilray was the first company to legally export medical cannabis products from North America to Australia and Europe. In 2017, the company is focused on expanding global distribution of its products to additional countries in Europe and Latin America.
